Immunotherapy Combination in Metastatic RCC Proves Effective – Cancer Network
|
Immunotherapy Combination in Metastatic RCC Proves Effective
Cancer Network Patients with metastatic renal cell carcinoma (RCC) had durable responses and manageable safety when treated with the combination of the immune checkpoint inhibitors nivolumab and ipilimumab, according to the results of the CheckMate 016 study … |
